Showing results (191-200 of 221) with videos related to
Sort By:
Pageof 23
Brain : a Journal of Neurology|November 18, 2009
The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatmentE Matthews, D Fialho, S V Tan, et al.Genomics|September 24, 1999
A fine integrated map of the SPG4 locus excludes an expanded CAG repeat in chromosome 2p-linked autosomal dominant spastic paraplegiaJ Hazan, C S Davoine, D Mavel, et al.Genes and Immunity|July 11, 2008
HLA-DRB1*15 allele influences the later course of relapsing remitting multiple sclerosisI Cournu-Rebeix, E Génin, E Leray, et al.Genes and Immunity|August 2, 2013
Genetic burden in multiple sclerosis familiesN Isobe, V Damotte, V Lo Re, et al.The Science of the Total Environment|April 19, 2015
A synthesis of postfire recovery traits of woody plants in Australian ecosystemsPeter J Clarke, Michael J Lawes, Brett P Murphy, et al.Journal of Neuroimmunology|January 8, 2000
Cytokines in genetic susceptibility to multiple sclerosis: a candidate gene approach. French Multiple Sclerosis Genetics GroupJ Reboul, C Mertens, F Levillayer, et al.Genome Research|December 10, 1998
Quality assessment of whole genome mapping data in the refined familial spastic paraplegia interval on chromosome 14qC Paternotte, D Rudnicki, C Fizames, et al.Neurology|September 25, 1998
A systematic study of oligodendrocyte growth factors as candidates for genetic susceptibility to MS. French Multiple Sclerosis Genetics GroupC Mertens, D Brassat, J Reboul, et al.Brain : a Journal of Neurology|October 1, 1996
Phenotype of autosomal dominant spastic paraplegia linked to chromosome 2A Dürr, C S Davoine, C Paternotte, et al.Nature Genetics|December 2, 2000
Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia)S Nicole, C S Davoine, H Topaloglu, et al.Pageof 23